Insys Ch. 11 Sale Of Controversial Drug OK'd With New Limits

By Vince Sullivan · September 19, 2019, 1:08 PM EDT

Insys Therapeutics Inc. received bankruptcy court approval Thursday in Delaware for a sale of its controversial pain medication Subsys after the buyer agreed to limit its marketing and distribution efforts to...

To view the full article, register now.
Try a seven day FREE Trial

Already a subscriber? Click here to login

Related Sections

Case Information

Case Title

Insys Therapeutics, Inc.

Case Number

1:19-bk-11292

Court

Delaware

Nature of Suit

Date Filed

June 10, 2019